April 9 (Reuters) – C4 Therapeutics said on Thursday it has entered into a deal focused on research and development of a type of cancer drug with Swiss drugmaker Roche that could be worth more than $1 billion.
(Reporting by Kunal Das in Bengaluru; Editing by Mrigank Dhaniwala)
